1Irbaz Bin Riaz,Majid Asawaeer,Haris Riaz,Wendy M.Gabriel,Ismail K.Tabash,Jawad Bilal,Joseph S.Alpert.Optimal anticoagulation duration of unfractionated and low molecular weight heparin in non-ST elevation acute coronary syndrome:A systematic review of the literature[J].International Journal of Cardiology,2014,177(2):461.
2Nilanchali Singh,Priya Varshney,Reva Tripathi,Y.M.Mala,Shakun Tyagi.Safety and Efficacy of Low Molecular Weight Heparin Therapy During Pregnancy:Three Year Experience at a Tertiary Nursing Center[J].The Journal of Obstetrics and Gynecology of India,2013,63(6):373.
3Camille Ettelaie,Donna Fountain,Mary Elizabeth W.Collier,Azza M.El Keeb,Yu Pei Xiao,Anthony Maraveyas.Low molecular weight heparin downregulates tissue factor expression and activity by modulating growth factor receptor-mediated induction of nuclear factor-κB[J].BBA-Molecular Basis of Disease,2011,1812(12):1591.